Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT04546620 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04546620
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2027-11-01
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.